Coffee as medicine? caffeine shows promise for rare movement disorder
NCT ID NCT04351360
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study looked at whether caffeine can ease involuntary movements in people with a rare genetic condition called ADCY5-related dyskinesia. Fifteen participants took caffeine and reported how much their symptoms improved. The goal was to see if at least 40% of people felt significant relief from their movement problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADCY5-RELATED DYSKINESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Département de Neurologie Groupe Hospitalier Pitié-Salpêtrière
Paris, 75651 PARIS Cedex 13, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.